Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Flecainide Reduces Ventricular Arrhythmias in Patients With Genotype RyR2-positive Catecholaminergic Polymorphic Ventricular Tachycardia.

Revista espanola de cardiologia (English ed.) - 1 Mar 2018

Wangüemert Pérez Fernando, Hernández Afonso Julio Salvador, Groba Marco María Del Val, Caballero Dorta Eduardo, Álvarez Acosta Luis, Campuzano Larrea Oscar, Pérez Guillermo, Brugada Terradellas Josep, Brugada Terradellas Ramón

Abstract excerpt

INTRODUCTION AND OBJECTIVES: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited disease characterized by polymorphic or bidirectional ventricular arrhythmias (VA) triggered by physical or emotional stress in young people with a structurally normal heart. Beta-blockers are the cornerstone of treatment, while flecainide has recently been incorporated into the therapeutic arsenal. The aim...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Arrhythmia Agents
Share to Death, Sudden, Cardiac

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Electrocardiography

Share to Flecainide

Share to Follow-Up Studies

Share to Polymorphic Catecholaminergic Ventricular Tachycardia

Share to Ryanodine Receptor Calcium Release Channel

Share to Tachycardia, Ventricular

Source

Identifiers

PMID: 28789916
DOI: 10.1016/j.rec.2017.04.032

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Flecainide Reduces Ventricular Arrhythmias in Patients With Genotype RyR2-positive Catecholaminergic Polymorphic Ventricular Tachycardia.PMID 28789916Read ↗

Catecholaminergic polymorphic ventricular tachycardia: a model for genotype-specific therapy.Semantic proximity Read ↗

Long-term Serial Exercise Stress Testing in Catecholaminergic Polymorphic Ventricular Tachycardia on Beta-Blocker and Flecainide TherapySemantic proximity Read ↗

Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia.Semantic proximity Read ↗

Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.Semantic proximity Read ↗

Catecholaminergic Polymorphic Ventricular Tachycardia.Semantic proximity Read ↗

Catecholaminergic polymorphic ventricular tachycardia.Semantic proximity Read ↗

Catecholaminergic polymorphic ventricular tachycardia.Semantic proximity Read ↗

Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature.Semantic proximity Read ↗

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.Semantic proximity Read ↗

Catecholaminergic Polymorphic Ventricular Tachycardia: A Review of Therapeutic Strategies.Semantic proximity Read ↗

Advances in the diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia.Semantic proximity Read ↗

50 Years of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) - Time to Explore the Dark Side of the Moon.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.